Workflow
Earnings estimate revisions
icon
Search documents
Wall Street Analysts Think Palomar (PLMR) Could Surge 36.15%: Read This Before Placing a Bet
ZACKS· 2026-02-26 15:56
Shares of Palomar (PLMR) have gained 1.7% over the past four weeks to close the last trading session at $121.68, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $165.67 indicates a potential upside of 36.2%.The average comprises six short-term price targets ranging from a low of $151.00 to a high of $183.00, with a standard deviation of $11.96. While the lowest estimate indicate ...
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
ZACKS· 2026-02-26 15:46
Aclaris Therapeutics (ACRS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.59%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.13 per share when it actually produced a loss of $0.12, delivering a surprise of +7.69%.Over the last four qua ...
TopBuild (BLD) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2026-02-26 15:46
TopBuild (BLD) came out with quarterly earnings of $4.5 per share, beating the Zacks Consensus Estimate of $4.39 per share. This compares to earnings of $5.13 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.47%. A quarter ago, it was expected that this insulation products company would post earnings of $5.22 per share when it actually produced earnings of $5.36, delivering a surprise of +2.68%.Over the last four quarters, t ...
Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-26 14:16
Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +25.79%. A quarter ago, it was expected that this biotechnology company would post earnings of $0.16 per share when it actually produced earnings of $0.23, delivering a surprise of +43.75%.Over the last fou ...
Celsius Holdings Inc. (CELH) Q4 Earnings and Revenues Surpass Estimates
ZACKS· 2026-02-26 14:15
分组1 - Celsius Holdings Inc. reported quarterly earnings of $0.26 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, and showing an increase from $0.14 per share a year ago, resulting in an earnings surprise of +38.37% [1] - The company achieved revenues of $721.63 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 13.08%, and significantly up from $332.2 million year-over-year [2] - Celsius has outperformed the S&P 500, with shares increasing about 10.7% since the beginning of the year compared to the S&P 500's gain of 1.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $718.17 million, and for the current fiscal year, it is $1.48 on revenues of $3.25 billion [7] - The Zacks Industry Rank indicates that the Food - Miscellaneous sector is currently in the bottom 19% of over 250 Zacks industries, suggesting potential challenges for stocks in this category [8]
Arhaus, Inc. (ARHS) Tops Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-26 14:15
Arhaus, Inc. (ARHS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +15.79%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.09, delivering a surprise of +12.5%.Over the last four quarters, the company has ...
Donaldson (DCI) Misses Q2 Earnings and Revenue Estimates
ZACKS· 2026-02-26 14:15
Donaldson (DCI) came out with quarterly earnings of $0.83 per share, missing the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.37%. A quarter ago, it was expected that this maker of filtration systems would post earnings of $0.93 per share when it actually produced earnings of $0.94, delivering a surprise of +1.08%.Over the last four quarters, ...
Acushnet (GOLF) Reports Q4 Loss, Tops Revenue Estimates
ZACKS· 2026-02-26 14:15
Acushnet (GOLF) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.69%. A quarter ago, it was expected that this golf products maker would post earnings of $0.85 per share when it actually produced earnings of $0.81, delivering a surprise of -4.71%.Over the last four quarters, the company h ...
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-26 14:15
Integra LifeSciences (IART) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.73%. A quarter ago, it was expected that this medical device maker would post earnings of $0.43 per share when it actually produced earnings of $0.54, delivering a surprise of +25.58%.Over the last four qua ...
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2026-02-26 14:15
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +67.87%. A quarter ago, it was expected that this physician practice management company would post earnings of $0.06 per share when it actually produced earnings of $0.05, delivering a surprise of -16.67%.Over the la ...